Related Experiment Video
Updated: Aug 11, 2026
Peptides from Phage Display Library Modulate Gene Expression in Mesenchymal Cells and Potentiate Osteogenesis in Unicortical Bone Defects
Published on: December 10, 2010
The effect of recombinant human osteogenic protein-1 on growth plate repair in a sheep model
B J Thomas1, S Byers, E W Johnstone
1Department of Paediatrics, University of Adelaide, SA, Australia.
Insights
Recombinant human osteogenic protein-1 (rhOP-1) enhances growth plate repair in sheep models by accelerating bone healing and promoting chondrogenic and osteogenic responses, potentially correcting limb deformities.
Area of Science:
- Orthopedics
- Regenerative Medicine
- Pediatric Bone Health
Background:
- Growth plate injuries in children can cause bone bridges, leading to limb length and angular deformities.
- The Langenskiöld procedure is a surgical technique to remove bone bridges impeding growth.
- Understanding the molecular repair mechanisms post-surgery is crucial for improving outcomes.
Purpose of the Study:
- To investigate the histological and molecular changes in growth plate repair after the Langenskiöld procedure.
- To evaluate the effect of recombinant human osteogenic protein-1 (rhOP-1) on growth plate regeneration.
- To determine if rhOP-1 promotes chondrogenic and osteogenic responses.
Main Methods:
- A sheep model was used to study growth plate injuries.
- The Langenskiöld procedure was performed to remove bone bridges.
- Animals received either rhOP-1 treatment or served as untreated controls.
- Histological and molecular analyses (collagen type I, osteopontin, decorin expression) were conducted at specific time points.
Main Results:
- rhOP-1 treatment increased growth plate height adjacent to the defect compared to controls.
- Expression of key bone repair molecules (collagen type I, osteopontin, decorin) was accelerated by rhOP-1.
- These molecules were detected by day 7 in rhOP-1 treated animals, versus day 56 in untreated animals.
Conclusions:
- rhOP-1 treatment significantly enhances growth plate repair following surgical intervention for bone bridge formation.
- The protein-1 treatment initiates a complex biological response that is both chondrogenic and osteogenic.
- These findings suggest rhOP-1's potential therapeutic value in managing pediatric growth plate injuries and associated deformities.
Abstract:
Injuries to the growth plate in children can result in bone bridge formation, which ultimately lead to limb length and angular deformities. The histological and molecular changes associated with growth plate repair following the Langenskiöld procedure, a surgical technique used to remove impeding bone bridges, in conjunction with administration of recombinant human osteogenic protein-1 (rhOP-1) were examined using a sheep model. Following treatment with rhOP-1 there was an increase in the height of the growth plate immediately adjacent to the defect compared to untreated animals. The expression of type I collagen, osteopontin and decorin were observed in the growth plate adjacent to the defect in the untreated animals at day 56, but this response was accelerated in the rhOP-1 treated animals, with these molecules seen as early as day 7. Therefore, treatment with rhOP-1 initiated a complex response that was both chondrogenic and osteogenic in nature.
